Compare KOD & CLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KOD | CLB |
|---|---|---|
| Founded | 2009 | 1936 |
| Country | United States | United States |
| Employees | 121 | 3500 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 864.2M |
| IPO Year | 2018 | 2023 |
| Metric | KOD | CLB |
|---|---|---|
| Price | $23.19 | $15.77 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 2 |
| Target Price | ★ $28.29 | $12.50 |
| AVG Volume (30 Days) | ★ 503.1K | 352.7K |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.25% |
| EPS Growth | ★ 32.60 | N/A |
| EPS | N/A | ★ 0.52 |
| Revenue | N/A | ★ $523,848,000.00 |
| Revenue This Year | N/A | $3.64 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $30.58 |
| Revenue Growth | N/A | ★ 2.76 |
| 52 Week Low | $1.92 | $9.72 |
| 52 Week High | $31.18 | $20.36 |
| Indicator | KOD | CLB |
|---|---|---|
| Relative Strength Index (RSI) | 41.55 | 31.61 |
| Support Level | $21.19 | $15.73 |
| Resistance Level | $29.17 | $17.05 |
| Average True Range (ATR) | 1.70 | 0.70 |
| MACD | -0.35 | -0.14 |
| Stochastic Oscillator | 8.59 | 9.86 |
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
Core Laboratories Inc provides reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.